Overexpression of C16orf74 is involved in aggressive pancreatic cancers

Clinical outcome of pancreatic ductal adenocarcinoma (PDAC) has not been improved in the last three decades due to the lack of effective molecular-targeted drugs. To identify a novel therapeutic target for PDAC, we have performed genome-wide anamysis and found that Homo sapiens chromosome 16 open re...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Toru, Katagiri, Toyomasa, Sato, Shoki, Kushibiki, Toshihiro, Hontani, Koji, Tsuchikawa, Takahiro, Hirano, Satoshi, Nakamura, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584151/
https://www.ncbi.nlm.nih.gov/pubmed/28881575
http://dx.doi.org/10.18632/oncotarget.10912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584151/
https://www.ncbi.nlm.nih.gov/pubmed/28881575
http://dx.doi.org/10.18632/oncotarget.10912

Ejemplares similares